Danaher had a disappointing 2024. His path to success next year runs through Wall Street
Life sciences company Danaher certainly hasn't been an easy stock to own this year. A wave of IPO startups on ...
Life sciences company Danaher certainly hasn't been an easy stock to own this year. A wave of IPO startups on ...